GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » EV-to-EBITDA

Curocell (XKRX:372320) EV-to-EBITDA : (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curocell EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Curocell's enterprise value is ₩439,603.16 Mil. Curocell does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Jun. 2023. Therefore, GuruFocus does not calculate Curocell's EV-to-EBITDA at this moment.

The historical rank and industry rank for Curocell's EV-to-EBITDA or its related term are showing as below:

XKRX:372320' s EV-to-EBITDA Range Over the Past 10 Years
Min: -81.64   Med: 0   Max: 0
Current: -19.52
XKRX:372320's EV-to-EBITDA is ranked worse than
100% of 451 companies
in the Biotechnology industry
Industry Median: 9.15 vs XKRX:372320: -19.52

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Curocell's stock price is ₩31600.00. Curocell does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023. Therefore, GuruFocus does not calculate Curocell's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Curocell EV-to-EBITDA Historical Data

The historical data trend for Curocell's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell EV-to-EBITDA Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - - - -21.68

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA - - - -21.68

Competitive Comparison of Curocell's EV-to-EBITDA

For the Biotechnology subindustry, Curocell's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curocell's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Curocell's EV-to-EBITDA falls into.


Curocell EV-to-EBITDA Calculation

Curocell's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=439603.155/
=

Curocell  (XKRX:372320) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Curocell's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=31600.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Curocell EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Curocell's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » EV-to-EBITDA
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines